Beta Bionics (BBNX) Stock Price
Beta Bionics Price
Over the last 3 years Beta Bionics grew revenue by 724.3% annually, reaching 100.25 M USD. For Beta Bionics, the net margin of -73.0% is up versus -36,173.7% a few years ago. The consensus 12-month price target for Beta Bionics is 22.00 USD, about 21.7% above where the stock trades today. Of 17 analysts, 13 rate the stock a buy — an overall Buy consensus.
Beta Bionics stock price
Beta Bionics business model & stock analysis
Frequently asked questions about Beta Bionics
Analysts currently set an average price target of 21.00 USD for the Beta Bionics stock (median: 22.00 USD), implying +16.2 % versus the latest price. The consensus is based on 17 analyst ratings.
17 analysts currently rate the Beta Bionics stock: 13 recommend buying, 4 holding and 0 selling. For 2026, analysts expect Beta Bionics to generate revenue of 126.68 M USD and earnings per share of -2.22 USD.
Converted at the current exchange rate, the Beta Bionics share trades at 16.13 EUR (18.08 USD).
The expected revenue of Beta Bionics is 126.68 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Beta Bionics is -90.14 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Beta Bionics is currently -8.13. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Beta Bionics stock.
The price-to-sales ratio (P/S) of Beta Bionics is currently 5.78. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Beta Bionics stock.
The Eulerpool Quality Score for Beta Bionics is 3/10.
The ISIN of Beta Bionics is US08659B1026. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Beta Bionics is BBNX. The ticker symbol is used to trade Beta Bionics shares on the stock exchange.
Beta Bionics stock
Beta Bionics Peer Group
All fundamentals and in-depth analysis of Beta Bionics
Our stock analysis for Beta Bionics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Beta Bionics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.